Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
Elisabeth MaillartFrançoise Durand-DubiefCéline LouapreBertrand AudoinBertrand BourreNathalie DeracheJonathan CironNicolas CollonguesJérome de SèzeMikael CohenChristine Lebrun-FrenayNawel HadhoumHélène ZéphirRomain DeschampsClarisse Carra-DallièrePierre LabaugePhilippe KerschenAlexis MontcuquetSandrine WiertlewskiDavid LaplaudGwenaëlle RunavotSandra VukusicCaroline PapeixRomain Marigniernull nullPublished in: Journal of neuroinflammation (2020)
A first episode of a double seronegative LETM is associated to a severe outcome and a high rate of relapse in the following 18 months, suggesting that an early immunosuppressive treatment may be beneficial in that condition.